Eton Pharmaceuticals Inc - ETON Net earnings per one share for the last twelve months

Eton Pharmaceuticals Inc (ETON) - corporate logo

The market valuation dynamics for Eton Pharmaceuticals (ETON) on GURU.Markets, where the indicator stands at 803.80, highlight the company's dependence on FDA verdicts and niche demand. The business relies on capturing pediatric endocrinology niches by implementing unique software in clinics. High profitability is secured by patent protection and a lack of alternatives for treating rare pathologies, creating a powerful defensive barrier for Eton Pharmaceuticals (ETON).

ETON: etonpharma.com Net earnings per share for the last 12 months 02/11/2024 - 11/18/2026

Eton Pharmaceuticals - analytical breakdowns and key metrics (ETON)

Fundamental company valuation:ETON - Eton Pharmaceuticals Inc
Brand item of Eton Corp

Institutional capital assesses the attractiveness of Eton Pharmaceuticals (ETON) through net earnings per share dynamics. This 12-month YoY EPS growth chart captures the actual change in profitability over a rolling year, excluding subjective forecasts. The stability of this metric confirms the effectiveness of a niche pediatric drug portfolio with low competition. The indicator's positive trajectory guarantees margin sustainability and high asset reliability.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months abeonatherapeutics.com|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)